MSB 0.00% $1.38 mesoblast limited

Mesoblast - takeover target?, page-55

  1. 16,468 Posts.
    lightbulb Created with Sketch. 776
    The aussie biotechs are very cheap compared to US and European comparables . The Chinese are buying in or are about to gobble up the sector , do trials in China and get faster approvals for its own people. I think we will see a boom in aussie biotech. Time to load up in the sector imo.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.